Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer

Poor prognosis cancers, such as pancreatic cancer, represent inherent challenges for ceramide-based nanotherapeutics due to metabolic pathways which neutralize ceramide to less toxic or pro-oncogenic metabolites. We have recently developed a novel 80 nanometer diameter liposomal formulation that inc...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jiang, Yixing, DiVittore, Nicole A, Kaiser, James M, Shanmugavelandy, Sriram S, Fritz, Jennifer L, Heakal, Yasser, Tagaram, Hephzibah Rani S, Cheng, Hua, Cabot, Myles C, Staveley-O'Carroll, Kevin F, Tran, Melissa A, Fox, Todd E, Barth, Brian M, Kester, Mark
Format: Artigo
Langue:Inglês
Publié: Landes Bioscience 2011
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3218384/
https://ncbi.nlm.nih.gov/pubmed/21795855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.12.7.15971
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires